Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves 1st at-home flu vaccine in U.S., a nasal spray
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider,
Nasal flu vaccine is approved for at-home use
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
FDA approves FluMist for upcoming flu season
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against the flu.
STAT
6d
Pharmalittle: We’re reading about an AstraZeneca bladder cancer drug, Genentech anxiety, and more
An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of ...
12d
AstraZeneca stock drops after lung cancer drug trial setback
London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that ...
12d
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
AstraZeneca Plc (NASDAQ:AZN) shared detailed results from the TROPION-Lung01 Phase 3 of datopotamab deruxtecan (Dato-DXd) ...
4d
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...
The Financial Times
12d
AstraZeneca shares hit by lung cancer drug trial results
Shares in
AstraZeneca
dropped nearly 5 per cent on Tuesday after its failure to hit a target in trials for a ...
Reuters
13d
AstraZeneca says lung cancer drug trial shows no significant improvement in overall survival
LONDON, Sept 9 (Reuters) - Detailed results from one of
AstraZeneca
's (AZN.L), opens new tab key lung cancer trials released on Monday showed that its experimental precision
drug
did not ...
FierceBiotech
8d
ESMO: AstraZeneca steps out from Daiichi's shadow, posting data on ADC rivals to AbbVie, Pfizer
AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...
2d
AstraZeneca: Poised for Growth with Promising Innovation Pipeline and Attractive Valuation
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...
SchaeffersResearch.com
9d
AstraZeneca Stock Downgraded on Drug Trial Results
Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) is 1.3% lower before the open, after a bear note from Deutsche Bank. The ...
cnbctv18
6d
AstraZeneca’s blockbuster drug scores major win in bladder cancer
In patients with muscle-invasive bladder cancer, Imfinzi reduced the risk of disease recurring by 32% when given alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback